Eve & Co Incorporated is pleased to announce its operating highlights and financial results for the quarter ended March 31, 2021. The financial statements and management’s discussion and analysis for such period are available on the System for Electronic Document Analysis and Retrieval (“SEDAR”) at www.sedar.com and on Eve & Co’s website at www.evecannabis.ca.
- The Company recognized gross sales of cannabis to the adult-use and wholesale markets of $2.47 million as compared to $0.47 million for the quarter ended March 31, 2020, representing an increase of 430%;
- During the first quarter of 2021, the Company completed an additional shipment of European Union certificate of Good Manufacturing Practice (“EU GMP”) certified cannabis to another of its German customers;
- On February 11, 2021, the Company announced that it had successfully completed its first shipment of cannabis products to New Brunswick. Its cannabis products can be purchased at licensed New Brunswick retailers and online; and
- On April 28, 2021, the Company announced that it had successfully completed its first shipment of cannabis products to Alberta. Its recreational cannabis products will be available online and can be purchased by the province’s privately owned licensed retailers.
ABOUT EVE & CO
Eve & Co, through its wholly-owned subsidiary Natural MedCo Ltd., holds cultivation and processing licences under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil and has received EU GMP certification. Natural MedCo Ltd. was Canada’s first female-founded licensed producer of medicinal marijuana and received its cultivation licence from Health Canada in 2016. Eve & Co is led by a team of agricultural experts and has a licensed 1,000,000 sq. ft. greenhouse located in Strathroy, Ontario.